Literature DB >> 14557608

Role of the serotonin 5-HT(2A) receptor in learning.

John A Harvey1.   

Abstract

This study reviews the role of the serotonin 5-HT2A receptor in learning as measured by the acquisition of the rabbit's classically conditioning nictitating membrane response, a component of the eyeblink response. Agonists at the 5-HT2A receptor including LSD (d-lysergic acid diethylamide) enhanced associative learning at doses that produce cognitive effects in humans. Some antagonists such as BOL (d-bromolysergic acid diethylamide), LY53,857, and ketanserin acted as neutral antagonists in that they had no effect on learning, whereas others (MDL11,939, ritanserin, and mianserin) acted as inverse agonists in that they retarded learning through an action at the 5-HT2A receptor. These results were placed in the context of what is known concerning the anatomical distribution and electrophysiological effects of 5-HT2A receptor activation in frontal cortex and hippocampus, as well as the role of cortical 5-HT2A receptors in schizophrenia. It was concluded that the 5-HT2A receptor demonstrates constitutive activity, and that variations in this activity can produce profound alterations in cognitive states.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14557608      PMCID: PMC218001          DOI: 10.1101/lm.60803

Source DB:  PubMed          Journal:  Learn Mem        ISSN: 1072-0502            Impact factor:   2.460


  88 in total

Review 1.  5-HT system and cognition.

Authors:  A Meneses
Journal:  Neurosci Biobehav Rev       Date:  1999-12       Impact factor: 8.989

2.  Cortical involvement in acquisition and extinction of trace eyeblink conditioning.

Authors:  A P Weible; M D McEchron; J F Disterhoft
Journal:  Behav Neurosci       Date:  2000-12       Impact factor: 1.912

3.  The physiological role of 5-HT2A receptors in working memory.

Authors:  Graham V Williams; Srinivas G Rao; Patricia S Goldman-Rakic
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

4.  Dose-related impairment of spatial learning by intrahippocampal scopolamine: antagonism by ondansetron, a 5-HT3 receptor antagonist.

Authors:  M Carli; R Luschi; R Samanin
Journal:  Behav Brain Res       Date:  1997-01       Impact factor: 3.332

5.  Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients.

Authors:  R C Arora; H Y Meltzer
Journal:  J Neural Transm Gen Sect       Date:  1991

6.  Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands.

Authors:  E L Barker; R S Westphal; D Schmidt; E Sanders-Bush
Journal:  J Biol Chem       Date:  1994-04-22       Impact factor: 5.157

7.  Effects of ritanserin on aversive classical conditioning in humans.

Authors:  R Hensman; F S Guimarães; M Wang; J F Deakin
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

8.  [3H]MDL 100,907 labels 5-HT2A serotonin receptors selectively in primate brain.

Authors:  J F López-Giménez; M T Vilaró; J M Palacios; G Mengod
Journal:  Neuropharmacology       Date:  1998-09       Impact factor: 5.250

9.  Inhibitory effect of hippocampal 5-HT1A receptors on human explicit memory.

Authors:  Fumihiko Yasuno; Tetsuya Suhara; Takashi Nakayama; Tetsuya Ichimiya; Yoshiro Okubo; Akihiro Takano; Tomomichi Ando; Makoto Inoue; Jun Maeda; Kazutoshi Suzuki
Journal:  Am J Psychiatry       Date:  2003-02       Impact factor: 18.112

10.  (S)-WAY 100135, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine.

Authors:  M Carli; R Luschi; R Samanin
Journal:  Eur J Pharmacol       Date:  1995-09-05       Impact factor: 4.432

View more
  61 in total

1.  Serotonin 5-HT2A receptors in the CA1 field of the hippocampus mediate head movements in the rabbit.

Authors:  Kuldip D Dave; Gayani S Fernando; Jennifer L Quinn; John A Harvey; Vincent J Aloyo
Journal:  Psychopharmacology (Berl)       Date:  2004-04-24       Impact factor: 4.530

2.  Stimulation of serotonin 2A receptors facilitates consolidation and extinction of fear memory in C57BL/6J mice.

Authors:  Gongliang Zhang; Herborg N Ásgeirsdóttir; Sarah J Cohen; Alcira H Munchow; Mercy P Barrera; Robert W Stackman
Journal:  Neuropharmacology       Date:  2012-06-18       Impact factor: 5.250

3.  Serotonin, via HTR2 receptors, excites neurons in a cortical-like premotor nucleus necessary for song learning and production.

Authors:  William E Wood; Peter V Lovell; Claudio V Mello; David J Perkel
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

4.  Selective serotonin 5-HT2A receptor antagonist EMD 281014 improves delayed matching performance in young and aged rhesus monkeys.

Authors:  Alvin V Terry; Jerry J Buccafusco; Gerd D Bartoszyk
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

Review 5.  REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics.

Authors:  R L Carhart-Harris; K J Friston
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

6.  Effect of serotonin depletion on 5-HT2A-mediated learning in the rabbit: evidence for constitutive activity of the 5-HT2A receptor in vivo.

Authors:  A G Romano; J L Quinn; R Liu; K D Dave; D Schwab; G Alexander; V J Aloyo; J A Harvey
Journal:  Psychopharmacology (Berl)       Date:  2005-12-21       Impact factor: 4.530

7.  Plasticity within striatal direct pathway neurons after neonatal dopamine depletion is mediated through a novel functional coupling of serotonin 5-HT2 receptors to the ERK 1/2 map kinase pathway.

Authors:  Pierre Brown; Charles R Gerfen
Journal:  J Comp Neurol       Date:  2006-09-20       Impact factor: 3.215

8.  Atypical antipsychotics and inverse agonism at 5-HT2 receptors.

Authors:  Laura C Sullivan; William P Clarke; Kelly A Berg
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

9.  Selective remodeling of rabbit frontal cortex: relationship between 5-HT2A receptor density and associative learning.

Authors:  John A Harvey; Jennifer L Quinn; Reijun Liu; Vincent J Aloyo; Anthony G Romano
Journal:  Psychopharmacology (Berl)       Date:  2003-12-17       Impact factor: 4.530

Review 10.  Serotonergic therapies for cognitive symptoms in Alzheimer's disease: rationale and current status.

Authors:  Maria J Ramirez; Mitchell K P Lai; Rosa M Tordera; Paul T Francis
Journal:  Drugs       Date:  2014-05       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.